Bisphosphonates for the Prevention and Treatment of Osteoporosis in Patients with Rheumatic Diseases: A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

Bisphosphonates for the Prevention and Treatment of Osteoporosis in Patients with Rheumatic Diseases: A Systematic Review and Meta-Analysis

Published:2013-12-06 Issue:12 Volume:8 Page:e80890
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Feng Zhiyun,Zeng Shumei,Wang Yue,Zheng Zhiyun,Chen Zhong

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference61 articles.

1. New developments in the pathogenesis and treatment of steroid-induced osteoporosis;SC Manolagas;J Bone Miner Res,1999

2. Cost of illness studies in rheumatic diseases;B Fautrel;Curr Opin Rheumatol,2002

3. Limited bone loss due to corticosteroids; a systematic review of prospective studies in rheumatoid arthritis and other diseases;AC Verhoeven;J Rheumatol,1997

4. The effect of systemic lupus erythematosus and long-term steroid therapy on bone mass in pre-menopausal women;F Pons;Br J Rheumatol,1995

5. Bone mineral content of the third lumbar vertebra during 18 months of prednisolone treatment for giant cell arteritis;E Nordborg;Clin Rheumatol,1993

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trattamento dell’osteoporosi da glucocorticoidi;L'Endocrinologo;2024-03-04

2. Real-world effectiveness of anti-osteoporosis medications for the prevention of incident hip and clinical vertebral fractures in patients on long-term glucocorticoid therapy: A nationwide health insurance claims database study in Japan;Bone;2023-01

3. Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club;Frontiers in Endocrinology;2022-06-09

4. Cost-Effectiveness of Sequential Denosumab/Zoledronic Acid Compared With Zoledronic Acid Monotherapy for Postmenopausal Osteoporotic Women in China;Frontiers in Pharmacology;2022-03-18

5. Comparable efficacy of denosumab and romosozumab in patients with rheumatoid arthritis receiving glucocorticoid administration;Modern Rheumatology;2022-03-01